Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
Novocure obtains approval for Optune Lua device in Japan to treat NSCLC
Novocure's Optune Lua Receives Approval for Advanced Lung Cancer ...
Novocure Receives Approval for Optune Lua in Japan for Non-Small Cell ...
Novocure's Optune Lua Gets Japan Approval for Advanced Lung Cancer ...
Novocure's Optune Lua Receives Japanese Approval for Advanced NSCLC ...
FDA Approves Optune Lua Device in NSCLC
Optune Lua is NOW FDA-APPROVED | Optune Lua® HCP
The first treatment of its kind for metastatic NSCLC, Optune Lua is ...
Optune Lua® by Novocure Receives CE Mark Approval for Treating ...
Japan Authorizes Optune Lua (Tumor Treating Fields) for Use in Advanced ...
Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of ...
Novocure's Optune Lua approved in Japan for NSCLC treatment | Medical ...
Optune Lua® from Novocure has received approval in Japan for treating ...
Disrupting Cancer Cells on the Go: Novocure’s Optune Lua Device for ...
Japan Approves Novocure’s Optune Lua for Advanced Non-Small Cell Lung ...
FDA Oks Optune Lua for Use With PD-1/PD-L1 Inhibitors in Metastatic NSCLC
The FDA granted approval this week for an external device (Optune Lua ...
Optune Lua Harnesses Frequencies to Revolutionize Cancer Care
Novocure's Optune Lua device approved in Japan to treat NSCLC
FDA Approves Optune Lua Device in NSCLC | AJMC
FDA Approves Novocure's Optune Lua for Metastatic NSCL - DeepNewz
FDA Oks Optune Lua for Use With PD-1/PD-L1 Inhibitors in Metastatic ...
AHN Cancer Institute is First in Pittsburgh Region to Offer Optune Lua ...
Optune Lua Receives CE Mark in Europe for Metastatic NSCLC
Optune Lua - The STELLAR Trial on Vimeo
Optune Lua (Tumor Treating Fields) | Mesothelioma Guide
Novocure Announces Japanese Approval of Optune (the NovoTTF-100A System ...
MOA for Optune Lua (full) - YouTube
Optune Lua TV Spot, 'Spark Within' - iSpot
NovoCure: FDA Approval for Optune Pax Triggers Fundamental Reevaluation ...
Optune Lua® | Optune Lua® is a wearable, portable, FDA-approved device ...
Optune Lua® | Optune Lua® is is a wearable, portable, FDA-approved ...
CCNW adds Optune Lua® for malignant pleural mesothelioma (MPM) to its ...
Novacure's Wearable Lung Cancer Treatment Device, Optune Lua, Receives ...
Downloadable Resources | Optune Lua®
mNSCLC Treatment | Optune Lua®
First in SC to Offer FDA-Approved Optune Lua® for Lung Cancer - Coastal ...
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer | AJMC
What Is Optune Lua®?
What is Optune Lua®? | Optune Lua®
Managing Alarms | Optune Lua®
Caring for your skin | Optune Lua®
Optune Lua™ Instructions for Use
The new Tumor Treating Fields therapy and the Optune device ...
About non-small cell lung cancer | Optune Lua®
(A) Optune patient feedback for handling and portability: Shown is ...
FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer | CURE
Novocure’s Second Generation Optune System for Glioblastoma Now FDA ...
Optune Lua® de Novocure reçoit l'approbation du marquage CE pour le ...
FDA Approves Tumor Treating Fields Device (Optune Lua) for Metastatic ...
Novocure submits tumor-treating fields device for FDA PMA
NovoCure Stock: Does Reward Outweigh The Risk? (NASDAQ:NVCR) | Seeking ...
FDA Approves Novocure's Lung Cancer Treatment Device - Mugglehead ...
肿瘤电场治疗法Optune Lua再获FDA批准治疗铂类进展转移性非小细胞肺癌，联用优于PDL1抑制剂单药医药新闻-ByDrug-一站式医药 ...
Market Research & Financial Analysis: ZLAB | Market_Financial_Analysis_ZLAB
St. Elizabeth Healthcare first in region to offer new, innovative ...
Tumor Treating Fields for mesothelioma: new promising data just ...
Using Robots for Extrapleural Pneumonectomy, Pleural Mesothelioma ...
FDA Approves Tumor Treating Fields Device (Optune Lua) for Metastatic NSCLC
肿瘤电场治疗Optune Lua再获FDA批准治疗转移性非小细胞肺癌-MedSci.cn
肿瘤电场治疗Optune Lua获批治疗转移性非小细胞肺癌|患者|肿瘤|治疗|个月|电场|-健康界
NovoCure: 2026 Pipeline Outlook Make This Stock A Speculative Buy ...
2025年9月15日日本厚生劳动省批准肿瘤电场疗法Optune Lua(TTFields)用于非小细胞肺癌-无癌家园
2024年10月15日美国FDA正式批准电场疗法TTFields(Optune Lua)联合多西他赛或PD-1/PD-L1抑制剂用于铂类疗法 ...
Novocure’s device for metastatic NSCLC treatment gains CE Mark
电场治疗仪,电场设备Optune Lua简单讲解_全球肿瘤医生网
I am proud to share Novocure had an exceptional Q3 with a strong ...
FDA快讯 | 肿瘤电场治疗Optune Lua获FDA批准用于转移性NSCLC_平台_医学_Faline
重磅！肿瘤电场疗法Optune Lua在日本获批，为晚期肺癌患者带来新选择-出国看病-盛诺一家
Mesothelioma TTFields | Benefits, Side Effects, & Costs
Current Patients - Coastal Cancer Center
CCNW is now offering Optune, a brain cancer treatment option.
Glioblastoma Update – Celldex Anti-EGFRvIII Vaccine and Improves ...
肿瘤电场治疗首次在中国上市！这到底是个啥？ – BLACK BOX TECH LAB
Central Alabama Radiation Oncology - CARO is one of the first centers ...
2025年9月15日日本厚生劳动省批准肿瘤电场疗法Optune Lua(TTFields)用于非小细胞肺癌_全球肿瘤医生网
肿瘤治疗场便携式设备Optune Lua在美获批用于治疗非小细胞肺癌 - 知乎
Waves of Hope: The Heartbreaking Journey Behind Noninvasive Tumor ...
'전자약' 선두 노보큐어, TTF 옵튠루아 FDA 승인 획득②
